Hematological Malignancies

Dose-response by tertiles of age at HL treatment Age at HL diagnosis <27.5 years

ERR: 20.0%

Age at HL diagnosis 27.5-36.4 years Age at HL diagnosis 36.5-50.9 years

ERR: 8.8% ERR: 4.2%

Relative Risk of CHD (RR)

Mean Heart Dose (Gy)

Van Nimwegen et al., submitted